Fylde and Wyre Policies

Fylde and Wyre Policies
Click each header to expand its content

Commissioning Policies

Fwccg-Commissioning-Policies-Introductory-Document 89 KB66
Fwccg-Commissioning-Policy-No-10-Treatment-of-Varicose-Veins 0.1 MB113
Fwccg-Commissioning-Policy-No-12-Testing-for-Malignant-Hyperthermia 0.1 MB59
Fwccg-Commissioning-Policy-No-17-Services-that-are-the-subject-of-Guidance-from-the-National-Institute-of-Health-and-Clinical-Excellence 0.1 MB53
Fwccg-Commissioning-Policy-No-19-Specified-Services-for-which-provision-in-service-agreements-may-be-limited 0.2 MB53
Fwccg-Commissioning-Policy-No-2-Choice-of-Service-Provider-for-Health-Care-Ver2 0.2 MB47
Fwccg-Commissioning-Policy-No-20-Specified-Expensive-Services 0.1 MB45
Fwccg-Commissioning-Policy-No-21-Specified-Non-clinical-issues 0.1 MB48
Fwccg-Commissioning-Policy-No-24-Complex-Cases-through-the-Commissioning-Panel 0.2 MB45
Fwccg-Commissioning-Policy-No-26-Lumbar-spine-procedures 0.3 MB36
Fwccg-Commissioning-Policy-No-3-Monitoring-Enforcing-of-CCG-Policies-for-the-Comm-of-Appropriate-Effective-and-Priority-Health-Care 0.1 MB45
Fwccg-Commissioning-Policy-No-34-Spinal-Cord-Stimulation 38 KB57
Fwccg-Commissioning-Policy-No-4-Application-Amendment-Waiver-of-Policies-for-the-Comm-of-Appropriate-Effective-and-Priority-Health-Care 0.4 MB45
Fwccg-Commissioning-Policy-No-4-att-Process-map-appeals-v3 0.1 MB47
Fwccg-Commissioning-Policy-No-9-Reversal-of-Sterilisation 0.1 MB54
Fwccg-Complementary-and-Alternative-Therapies-new-Jan-2018 88 KB50
Fwccg-Policy For Commissioning Spinal Injection Radiofrequency Denervation For Low Back Pain V1 0.6 MB58
Fwccg-Policy Number 1 Statement Of Principles 0.3 MB45
Fwccg-Policy Number 2 General Policy IFR Decision Making 0.4 MB61
Fwccg-Policy Number 3 Considering Applications For Exceptionality 0.3 MB98
Fwccg-Policy-for-Assisted-Conception-Services 0.3 MB102
Fwccg-Policy-for-cosmetic-procedures-0318 64 KB113
Fwccg-Policy-for-Endoscopic-Procedures-on-the-Knee-Joint-Cavity-July-2017-v6 . 0.2 MB48
Fwccg-Policy-for-excision-of-the-uterus-v1 0.1 MB51
Fwccg-Policy-for-Grommets-v1 0.1 MB49
Fwccg-Policy-for-Hip-Arthroscopy-0318 42 KB51
Fwccg-Policy-for-hysteroscopy-0318 44 KB39
Fwccg-Policy-for-insulin-pump-provision-v1 0.1 MB36
Fwccg-Policy-for-Male-Circumcision-v4 0.2 MB63
Fwccg-Policy-for-photorefractive-surgery-v1 0.1 MB44
Fwccg-Policy-for-Surgical-Release-of-Trigger-Finger-Vs5-141216 0.2 MB63
Fwccg-Policy-for-Surgical-Treatment-of-Carpal-Tunnel-Syndrome-V5-050717 0.2 MB48
Fwccg-Policy-for-Tonsillectomy-Adeno-Tonsillectomy-V8-050717 0.2 MB64
Fwccg-Policyfor-Dilatation-and-Curettage-0318 45 KB37
Policy for Chalazia Removal 0.2 MB38
Policy for Dupuytren's contracture 0.3 MB46
Policy for ganglia excision 0.2 MB37
Policy for Glucose Monitoring Devices (March 19 amends) 0.3 MB110
Policy for Haemorrhoid surgery 0.2 MB36
Policy for snoring surgery 0.2 MB34
Policy subacromial decompression 0.2 MB34
Policy_for_hysteroscopy_v2_020519 0.1 MB16
Policy_for_Reversal_of_Sterilisation_v1_070319 0.1 MB20
Policy_for_varicose_veins_ v1_020519 0.1 MB24

Commissioning Policy summaries

Corporate Policies

Information Governance

Medicines Optimisation

Actipatch for pain management 0.6 MB103
Albiglutide for type-2 diabetes mellitus 0.3 MB71
Alprostadil Cream For ED 0.3 MB54
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB70
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB65
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB55
Brimonidine For Erythema Of Rosacea 0.1 MB56
Brivaracetam for epilepsy 0.3 MB62
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB70
Certolizumab For Psoriatic Arthritis 0.1 MB51
Co-Proxamol For pain management 0.3 MB108
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB59
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB63
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB61
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB37
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB113
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB45
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB44
Denosumab for GIO 0.2 MB34
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB63
Eflornithine-cream-for-facial-hirsutism 0.2 MB55
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB36
Eslicarbazepine For Focal Seizures 0.1 MB47
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB63
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB62
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB35
Gluten-Free-Food-Products 0.3 MB54
Guanfacine-for-ADHD 0.3 MB62
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB50
Insulin Degludec And Liraglutide 0.2 MB42
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB51
Insulin-Degludec-for-DM 0.3 MB53
Insulin-Detemir-for-DM 0.2 MB38
Insuline-Glargine-for-T1DM 0.3 MB41
Insuline-Glargine-for-T2DM 0.3 MB45
Invicorp-injection-for-erectile-dysfunction 0.3 MB69
Ivermectin-cream-for-rosacea 0.3 MB53
JIA Policy For Adults (Version 1.0) 0.2 MB41
Lamotrigine-for-trigeminal-neuralgia 0.3 MB57
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB75
Levonorgestrel 13.5mg IUD 0.3 MB38
Lidocaine Plasters For PHN 0.2 MB46
Lidocaine-plasters-for-unlicensed-indications 0.3 MB71
Liothyronine-for-refractory-hypothyroidism 0.2 MB74
Liraglutide-for-obesity 0.3 MB56
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB62
Lisdexamfetamine-for-ADHD-update 0.3 MB52
Lurasidone-for-Schizophrenia 0.3 MB66
Magnaspartate For Hypomagnesaemia 0.3 MB49
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB49
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB39
Midazolam-Epistatus-for-seizures 0.2 MB54
Opicapone-for-Parkinsons-disease-v2 0.5 MB73
Ospemifene for VVA 0.2 MB49
Oxycodone-Naloxone-for-Restless-legs 0.3 MB44
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB141
Patiromer-for-hyperkalaemia 0.3 MB50
Patiromer-for-hyperkalaemia 2 0.3 MB57
Phosphodiesterase Type-5 Inhibitors 0.2 MB44
Pitolisant-for-Narcolepsyv2 0.3 MB44
Policy On Brand Inhaler Prescribing 0.3 MB63
Probiotics And VSL 0.3 MB53
Relvar Ellipta for COPD and asthma in adults 63 KB42
Rituximab-for-AIHA 0.4 MB57
Rituximab-for-ITP 0.4 MB59
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB59
Safinamide-for-Parkinsons-disease 0.3 MB63
Second Line Anti-TNF For PsA 0.2 MB58
Second-generation-LA-antipsychotics 0.3 MB64
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB44
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB58
Semaglutide for type 2 DM 0.2 MB35
Silk Garments For Eczema And Dermatitis 0.2 MB43
Simbrinza for chronic open angle glaucoma 0.1 MB41
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB59
Spironolactone For Acne 0.1 MB47
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB50
Tadalafil daily 0.3 MB68
Tapentadol for neuropathic pain in non-palliative care 0.4 MB51
Tapentadol for non-specific pain 0.2 MB58
Testosterone For Female Sexual Dysfunction 0.1 MB34
Tiotropium For Asthma 0.2 MB41
Tocilizumab SC For RA 0.1 MB41
Trelegy inhaler for COPD 0.3 MB55
Trimbow inhaler for COPD 0.4 MB62
Trimbow-inhaler-for-COPD 0.4 MB4
Ulipristal acetate for uterine fibroids 0.5 MB60
Umeclidinium For COPD 0.2 MB41
Vedolizumab For Crohn's Disease 0.2 MB33
Vesomni For Benign Prostatic Hyperplasia 0.1 MB40
Vitamins (inc Renavit) For Dialysis 0.3 MB52
Waterproof Cast Cover Policy 0.1 MB46
Xonvea for nausea and vomiting in pregnancy 0.1 MB30

Last updated on 8 February 2019 at 13:53 by communications manager